The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

These vaccines work by stimulating the body's immune response against cancer cells, often by training immune cells (like T ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

A new study published in the journal Nature emphasizes the promise of a personalized vaccine, autogene cevumeran, in treating ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients ...